Watch Ticker

Equillium, Inc. Common Stock

Go to Equillium, Inc. Common Stock Website

$0.58

-0.01 (-2.10%)

Live

Previous Close

$0.596

Day Range

$0 - $0

Previous Day Range

$0.5279 - $0.6

Market Cap

$20.1 million USD

Day Vol.

Previous Day Vol.

2.3 million

Currency

USD

Primary Exchange

Nasdaq

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its pro...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight

The graft versus host disease market is experiencing significant growth, driven by the adoption of branded therapies, a strong pipeline with the anticipated launch of over 10 new drugs, and increased awareness of GvHD management. Innovative treatments and ongoing research are expected to further expand market opportunities.

Related tickers: EQ, TAK, CSLLY, SNDX, MESO, INCY, PFE, BMY, CELGr, RHHBY, MCRB.

Read Full Article

N/A - Vivtex Enters New Research Agreement with Equillium to Develop GI-targeted Formulations for its First-in-Class Oral, Bi-Specific Peptide Therapy

Vivtex and Equillium have entered a research collaboration to develop an optimized oral version of Equillium's EQ302, a bi-specific peptide inhibitor of IL-15 and IL-21, for the treatment of gastrointestinal disorders.

Related tickers: EQ.

Read Full Article

Trending Tickers

Please sign in to view